This Article Full Text Full Text (PDF) All Versions of this Article: 42/5/925    most recent 01.HYP.0000097605.35343.64v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chan, C. T. Articles by Floras, J. S. Search for Related Content PubMed PubMed Citation Articles by Chan, C. T. Articles by Floras, J. S.

(Hypertension. 2003;42:925.)
© 2003 American Heart Association, Inc.

Scientific Contributions

Short-Term Blood Pressure, Noradrenergic, and Vascular Effects of Nocturnal Home Hemodialysis

Christopher T. Chan; Paula J. Harvey; Peter Picton; Andreas Pierratos; Judith A. Miller; John S. Floras

From the Department of Medicine, University Health Network and Mount Sinai Hospital (C.T.C., P.J.H., P.P., J.A.M., J.S.F.), University of Toronto, Toronto, Ontario, Canada; and Humber River Regional Hospital (A.P.), University of Toronto, Toronto, Ontario, Canada.

Correspondence to Dr J.S. Floras, Suite 1614, 600 University Ave, Toronto, Ontario, Canada, M5G 1X5. E-mail john.floras{at}utoronto.ca

Long-term nocturnal hemodialysis, which uses longer and more frequent sessions than conventional hemodialysis, lowers clinic blood pressure and left ventricular mass. We tested the hypotheses that short-term nocturnal hemodialysis would (1) reduce ambulatory blood pressure; (2) cause peripheral vasodilation; (3) lower plasma norepinephrine concentration; and (4) improve the arterial response to reactive hyperemia (a marker of endothelium-dependent vasodilation). We studied 18 consecutive patients (age, 41±2; [mean±SEM]) before and 1 and 2 months after conversion from conventional (three 4-hour sessions per week) to nocturnal (six 8-hour sessions per week) hemodialysis. As the dialysis dose per session (Kt/V) increased from 1.24±0.06 to 2.04±0.08 after 2 months (P=0.02), symptomatic hypotension developed and most antihypertensive medications were withdrawn. Nocturnal hemodialysis nonetheless lowered 24-hour mean arterial pressure (from 102±3 to 90±2 mm Hg after 2 months; P=0.01), total peripheral resistance (from 1967±235 to 1499±191 dyne · s · cm^-5; P<0.01) and plasma norepinephrine (from 2.66±0.4 to 1.96±0.2 nmol; P=0.04). Endothelium-dependent vasodilation could not be elicited during conventional hemodialysis (-2.7±1.8%) but was restored (+8.0±1.0%; P=0.001) after 2 months of nocturnal hemodialysis. The brachial artery response to nitroglycerin also improved (from 6.9±2.8 to 15.7±1.6%; P<0.05). Nocturnal hemodialysis had no effect on weight or on stroke volume. Rapid reversal of these markers of adverse cardiovascular events with more intense hemodialysis may translate into improved outcome in this high-risk group of patients.

Key Words: blood pressure • catecholamines • hemodynamics • hemodialysis • endothelium • muscle, smooth, vascular

This article has been cited by other articles:

				M. Copland, D. Murphy-Burke, A. Levin, R. S. Singh, P. Taylor, and L. Er Implementing a home haemodialysis programme without adversely affecting a peritoneal dialysis programme Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2546 - 2550. [Abstract] [Full Text] [PDF]

				A. Bugeja, N. Dacouris, A. Thomas, R. Marticorena, P. McFarlane, S. Donnelly, and M. Goldstein In-center Nocturnal Hemodialysis: Another Option in the Management of Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., April 1, 2009; 4(4): 778 - 783. [Abstract] [Full Text] [PDF]

				C. T. Chan, P. P. Liu, S. Arab, N. Jamal, and H. A Messner Nocturnal Hemodialysis Improves Erythropoietin Responsiveness and Growth of Hematopoietic Stem Cells J. Am. Soc. Nephrol., March 1, 2009; 20(3): 665 - 671. [Abstract] [Full Text] [PDF]

				P. Komenda, M. Copland, L. Er, O. Djurdjev, and A. Levin Outcomes of a provincial home haemodialysis programme--a two-year experience: establishing benchmarks for programme evaluation Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2647 - 2652. [Abstract] [Full Text] [PDF]

				M. M. Sood, R. P. Pauly, C. Rigatto, and P. Komenda Left ventricular dysfunction in the haemodialysis population NDT Plus, August 1, 2008; 1(4): 199 - 205. [Abstract] [Full Text] [PDF]

				M. Barua, M. Hladunewich, J. Keunen, A. Pierratos, P. McFarlane, M. Sood, and C. T. Chan Successful Pregnancies on Nocturnal Home Hemodialysis Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 392 - 396. [Abstract] [Full Text] [PDF]

				J. M. Beecroft, V. Hoffstein, A. Pierratos, C. T. Chan, P. McFarlane, and P. J. Hanly Nocturnal haemodialysis increases pharyngeal size in patients with sleep apnoea and end-stage renal disease Nephrol. Dial. Transplant., February 1, 2008; 23(2): 673 - 679. [Abstract] [Full Text] [PDF]

				J. Spaak, A. C. Merlocco, G. J. Soleas, G. Tomlinson, B. L. Morris, P. Picton, C. F. Notarius, C. T. Chan, and J. S. Floras Dose-related effects of red wine and alcohol on hemodynamics, sympathetic nerve activity, and arterial diameter Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H605 - H612. [Abstract] [Full Text] [PDF]

				C. T. Chan, C. F. Notarius, A. C. Merlocco, and J. S. Floras Improvement in exercise duration and capacity after conversion to nocturnal home haemodialysis Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3285 - 3291. [Abstract] [Full Text] [PDF]

				B. F. Culleton, M. Walsh, S. W. Klarenbach, G. Mortis, N. Scott-Douglas, R. R. Quinn, M. Tonelli, S. Donnelly, M. G. Friedrich, A. Kumar, et al. Effect of Frequent Nocturnal Hemodialysis vs Conventional Hemodialysis on Left Ventricular Mass and Quality of Life: A Randomized Controlled Trial JAMA, September 19, 2007; 298(11): 1291 - 1299. [Abstract] [Full Text] [PDF]

				P. J. Blankestijn SYMPATHETIC HYPERACTIVITY--A HIDDEN ENEMY IN CHRONIC KIDNEY DISEASE PATIENTS Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S293 - S297. [Abstract] [Full Text] [PDF]

				H. Kocak, J. Ly, and C. T. Chan Improvement in open-angle glaucoma by nocturnal home haemodialysis Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2647 - 2649. [Full Text] [PDF]

				D. Yuen, A. Pierratos, R. M.A. Richardson, and C. T. Chan The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1407 - 1412. [Abstract] [Full Text] [PDF]

				K. Jindal, C. T. Chan, C. Deziel, D. Hirsch, S. D. Soroka, M. Tonelli, and B. F. Culleton CHAPTER 1: Hemodialysis Adequacy in Adults J. Am. Soc. Nephrol., March 1, 2006; 17(3_suppl_1): S4 - S7. [Full Text] [PDF]

				K. Jindal, C. T. Chan, C. Deziel, D. Hirsch, S. D. Soroka, M. Tonelli, and B. F. Culleton CHAPTER 5: Frequent and Sustained Hemodialysis J. Am. Soc. Nephrol., March 1, 2006; 17(3_suppl_1): S24 - S27. [Full Text] [PDF]

				C. T. Chan, P. J. Harvey, R. Boger, A. Pierratos, and J. S. Floras Letter to the Editor: Dissociation Between the Short-Term Effects of Nocturnal Hemodialysis on Endothelium Dependent Vasodilation and Plasma ADMA Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2685 - 2686. [Full Text] [PDF]

				C. T. Chan, S. H. Li, and S. Verma Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease Am J Physiol Renal Physiol, October 1, 2005; 289(4): F679 - F684. [Abstract] [Full Text] [PDF]

				F. Locatelli, U. Buoncristiani, B. Canaud, H. Kohler, T. Petitclerc, and P. Zucchelli Dialysis dose and frequency Nephrol. Dial. Transplant., February 1, 2005; 20(2): 285 - 296. [Abstract] [Full Text] [PDF]

				S R Johnson, P J Harvey, J S Floras, M Iwanochko, D Ibanez, D D Gladman, and M Urowitz Impaired brachial artery endothelium dependent flow mediated dilation in systemic lupus erythematosus: preliminary observations Lupus, August 1, 2004; 13(8): 590 - 593. [Abstract] [PDF]